220 likes | 324 Views
Activation/Detoxication. Non-polar (lipophilic). Hydrophobic. XENOBIOTIC. Phase I Metabolism. Oxidation. Can accumulate in tissues. Solubility in lipids. INTERMEDIATE METABOLITE. Phase II Metabolism. Conjugation. Solubility in water. May be reactive/toxic. WATER-SOLUBLE METABOLITE.
E N D
Non-polar (lipophilic) Hydrophobic XENOBIOTIC Phase I Metabolism Oxidation Can accumulate in tissues Solubility in lipids INTERMEDIATE METABOLITE Phase II Metabolism Conjugation Solubility in water May be reactive/toxic WATER-SOLUBLE METABOLITE Lipophobic Hydrophilic (Polar) ELIMINATION
METABOLIC SCHEME OF BENZO[a]PYRENE (BP, B[a]P) proximate metabolites ultimate active metabolite BPDE 7,8-Quinone 7,8-catechol
Another example Organophosphate Insecticides: • Parathion • Malathion
Hydrolysis enzymes • Serum cholinesterase BChE • Serum paraoxonase PON1 • Polymorphisms in PON1 – differential sensitivity Heart disease Atherosclerosis Gulf War Syndrome
Effect is the outcome of interaction between susceptibility and exposure
Target organs • What makes a particular organ a target for toxicity / infection ? • What makes a particular organ or species susceptible ?
Portal of entry to Blood to Target Organ Location, location, location e.g. Intestine to hepatic portal vein to liver to vena cava to heart to lungs back to heart to aorta to rest of body
Lungs Vena cava Aorta Liver Hepatic portal vein Intestines
Gut flora • Reductions • nitro to amine • Hydrolyses • Cleavage of glucuronides
Reaction Glucuronidation
C O O H O H o o H O O H O H Reaction De-glucuronidation b-glucuronidase Aglycone Conjugate
Enterohepatic recirculation(EHC) Liver Intestine
Presence/absence of receptors • Estrogen receptors, Ah receptor • Presence/absence of transporters/carriers • Resistance to chemotherapy • Presence of repair mechanisms • DNA repair • Balance of metabolic activation/detoxication
Factors affecting xenobiotic metabolism • Intrinsic • Species, strain, gender, age, genotype • Physiological status • Temperature, time of day, season, • Health status, disease, stress • Diet, nutritional status • Related to exposure • Route of administration, frequency and size of dose, co-exposures (induction, inhibition)
Genetic polymorphisms • CYP2D6 Debrisoquine hydroxylation (poor and extensive metabolizers) • Acetylation (fast and slow acetylators) • GSTM null genotype
Changes in P450 levels with ageRats M: 2C6, 2C11, 3A2 F: 2A1, 2C6, 2C12 2A1 2C6 3A2
Cross-species extrapolation The basic problem: data determined in experimental animals Information needed about target species (usually humans) • What factors are similar ? • What factors are different ?